Table 4.
The effects of intervention between the control and intervention groups (N=102).
| Variable | Change from baseline, mean (SD) | Between-groups difference, mean (95% CI) | P value | |||||
|
|
Control (n=54) | Intervention (n=48) |
|
Intervention vs control | Treatment×time | |||
| Weight (kg) | ||||||||
|
|
3 months | –1.57 (2.98) | –2.07 (3.11) | 0.50 (–0.70 to 1.69) | .41 | .65 | ||
|
|
6 months | –0.79 (3.76) | –1.54 (2.74) | 0.74 (–0.56 to 2.05) | .26 | .59 | ||
| Weight loss (%) | ||||||||
|
|
3 months | –1.82 (3.40) | –2.52 (3.51) | 0.70 (–0.66 to 2.06) | .31 | .32 | ||
|
|
6 months | –1.07 (3.34) | –2.08 (3.44) | 1.01 (–0.54 to 2.55) | .20 | .15 | ||
| BMI (kg/m2) | ||||||||
|
|
3 months | –0.57 (1.05) | –0.75 (1.09) | 0.18 (–0.24 to 0.60) | .40 | .47 | ||
|
|
6 months | –0.32 (1.32) | –0.58 (0.98) | 0.26 (–0.20 to 0.72) | .27 | .41 | ||
| Liver fat score | ||||||||
|
|
6 months | –14.91 (96.31) | –11.60 (30.34) | –3.30 (–32.09 to 25.48) | .82 | N/Aa | ||
| ASTb,c,d (IU/L) (n=92) | ||||||||
|
|
6 months | –0.90 (23.52) | –4.09 (12.21) | 3.20 (–4.73 to 11.12) | .43 | N/A | ||
| ALTc,e,f (IU/L) (n=92) | ||||||||
|
|
6 months | –5.73 (27.04) | –8.05 (15.96) | 2.32 (–6.84 to 11.48) | .62 | N/A | ||
| ɣ-GTc,g,h (n=83) | ||||||||
|
|
6 months | –3.96 (25.07) | –12.16 (34.36) | 8.20 (–4.81 to 21.21) | .21 | N/A | ||
| Self-management | ||||||||
|
|
3 months | 0.09 (0.47) | 0.30 (0.47) | –0.21 (–0.40 to –0.03) | .025 | .12 | ||
|
|
6 months | 0.03 (0.55) | 0.37 (0.61) | –0.34 0.57 to –0.11) | .004 | .006 | ||
| Knowledge | ||||||||
|
|
3 months | –0.31 (1.68) | 0.50 (1.38) | –0.81 (–1.42 to –0.21) | .009 | .07 | ||
|
|
6 months | –0.35 (1.59) | 0.29 (1.47) | –0.64 (–1.25 to –0.04) | .04 | .23 | ||
| Self-efficacy | ||||||||
|
|
3 months | –0.10 (0.93) | –0.03 (1.12) | –0.07 (–0.47 to 0.33) | .73 | .97 | ||
|
|
6 months | 0.04 (1.03) | 0.29 (1.10) | –0.26 (–0.67 to 0.16) | .230 | .45 | ||
| Fatigue | ||||||||
|
|
3 months | 0.13 (1.24) | –0.13 (1.36) | 0.27 (–0.24 to 0.78) | .30 | .46 | ||
|
|
6 months | 0.22 (1.39) | –0.60 (1.42) | 0.82 (0.27 to 1.37) | .004 | .02 | ||
| Depression | ||||||||
|
|
3 months | –0.64 (4.14) | –1.00 (3.73) | 0.36 (–1.19 to 1.92) | .65 | .85 | ||
|
|
6 months | –0.08 (4.05) | –1.75 (3.84) | 1.67 (0.11 to 3.22) | .04 | .26 | ||
| Quality of life | ||||||||
|
|
3 months | 1.17 (8.01) | 3.71 (8.11) | –2.54 (–5.71 to 0.63) | .12 | .59 | ||
|
|
6 months | 1.24 (9.70) | 6.71 (12.21) | –5.47 (–9.78 to –1.16) | .01 | .13 | ||
aN/A: not applicable.
bAST: aspartate aminotransferase.
cTotal numbers were not 102 because of missing data.
dSamples for the analysis in the control and intervention group were 49 and 43, respectively.
eALT: alanine transaminase. Samples for the analysis in the control and intervention group were 49 and 43, respectively.
fSamples for the analysis in the control and intervention group were 49 and 43, respectively.
gɣ-GT: gamma-glutamyl transferase.
hSamples for the analysis in the control and intervention group were 45 and 38, respectively.